| Rebecca Brush, NP | |
|
133 Fairfield St, Saint Albans, VT 05478-1726 | |
| (802) 524-5911 | |
| (802) 524-1057 |
| Full Name | Rebecca Brush |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 133 Fairfield St, Saint Albans, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699026583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 101-00119779 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Brush, NP 133 Fairfield St, Saint Albans, VT 05478-1726 Ph: (802) 524-5911 | Rebecca Brush, NP 133 Fairfield St, Saint Albans, VT 05478-1726 Ph: (802) 524-5911 |
News Archive
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
The suicide rate among people with epilepsy is 22 percent higher than the general population, according to a new study released by the Centers for Disease Control and Prevention, published in Epilepsy & Behavior.
Columbia Laboratories, Inc. announced today that it has closed the sale of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc.. Columbia's business now consists of its royalty and manufacturing revenues, potential milestone payments, its collaboration with Watson on the development of next-generation progesterone products, and its novel bioadhesive drug delivery technologies and other products.
University of Alberta researchers are looking at exercise as a new way to slow the degenerative processes of ALS, commonly known as Lou Gehrig's disease. Dr. Kelvin Jones, a recipient of this year's ALS Canada Discovery Grant, has been pioneering research in this field for four years, using mice genetically altered to present familial ALS. He's found that exercise has a positive impact on the mice, slowing the disease significantly.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 3 days ago
Mrs. Lindsay Claire Arzberger, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 260 Crest Rd, Suite 103, Saint Albans, VT 05478 Phone: 802-524-8911 | |
Sandra Robinson, APRN, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-5911 | |
Ms. Kimberly R. Liberty, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 3 Crest Rd, Saint Albans, VT 05478 Phone: 802-524-4554 | |
Nicholas Adam Nowalk, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 107 Fisher Pond Rd, Saint Albans, VT 05478 Phone: 802-393-6412 | |
Jenna E Purdell, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 596 Sheldon Rd, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Beth Paquin, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-5911 | |
Stacey Bouchard, APRN-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 12 Crest Rd, Saint Albans, VT 05478 Phone: 802-524-4554 Fax: 802-527-6792 |